Inflammatory bowel diseases and Parkinson's disease
Open accessThe DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
The etiology of Parkinson’s disease (PD) is multifactorial, with genetics, aging, and environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites, and degeneration of substantia nigra dopamine neurons are the pathological hallmarks of PD. Inflammatory responses manifested by glial reactions, T cell infiltration, and increased expression of inflammatory cytokines, as well as other toxic mediators derived from activated glial cells, are currently recognized as prominent features of PD. Experimental, clinical and epidemiological data suggest that intestinal inflammation contributes to the pathogenesis of PD, and the increasing number of studies suggests that the condition may start in the gastrointestinal system years before any motor symptoms develop. Patients with inflammatory bowel disease (IBD) have a higher risk of developing PD compared with non-IBD individuals. Gene association study has found a genetic link between IBD and PD, and an evidence from animal studies suggests that gut inflammation, similar to that observed in IBD, may induce loss of dopaminergic neurons. Based on preclinical models of PD, it is suggested that the enteric microbiome changes early in PD, and gut infections trigger α-synuclein release and aggregation. In this paper, the possible link between IBD and PD is reviewed based on the available literature. Given the potentially critical role of gastrointestinal pathology in PD pathogenesis, there is reason to suspect that IBD or its treatments may impact PD risk. Thus, clinicians should be aware of PD symptoms in IBD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies have shown that patients with inflammatory bowel diseases have a higher risk of Parkinson's disease.”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
The cited source says what the claim attributes to it.
In the citing paper
“In autoimmune conditions, peripheral inflammation caused by gut inflammation may trigger a-synuclein aggregation, increasing the permeability of intestinal tract and BBB and leading to neuroinflammation.98”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, inflammatory bowel diseases and Parkinson's disease share some common genetic factors.98”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“a pathway to spread the pathological protein to the 636 brain according to the Braak’s theory [5, 131].”
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“In fact, neurochemical and behavioral effects were not present in vagotomized mice, identifying the vagus as the major modulatory constitutive communication pathway between microbiota and the brain [128].”
BackgroundGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712 · cited 1×
“The major 92 symptoms of UC are diarrhea, rectal bleeding, tenes93 mus, passage of mucus, and crampy abdominal pain 94 [20].”
BackgroundCytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Research works printed but not linked: 5
- Machado A, 2011, Adv Neurol, 2011, 393769
- Villumsen M, 2018, Gut, 68, 1722
- Grathwohl S, 2019, bioRxiv, 505164
- Carabotti M, 2015, Ann Gastroenterol, 28, 203
- Berge N, 2019, Acta Neuropathol
Cited by
Items 101–150 of 150
Mendonça, I. P., da Silva, R. S., de Paiva, I. H. R., Costa, B. L. D. S. A., Teixeira, K. P. D. S. B., de Souza, J. R. B., & Peixoto, C. A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02152-2 · Cited by 6
Zhang, W., Jiao, Y., Wen, H., Bin, X., Xuefei, W., Lan, J., & Liuyin, Z. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1407241 · Cited by 6
Chen, Y., Liu, J., Zhong, S., Zhang, T., Jin, Y., Zhang, J., Chen, Y., Liang, J., Chen, Y., Hou, S., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1536091 · Cited by 5
Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease
Zhang, Z., Ye, P., Kong, W.-X., Li, J., Zhu, S., Lin, Y.-W., Xu, P., & Guo, W. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05153-4 · Cited by 5
Clinical and Pre-Clinical Evidence for Enteric α-Synuclein Involvement in Parkinson's Disease
Kochman, E. M., Akhtar, K., Ali, A., & Shin Damian, S. (2021) · International Journal of Neurodegenerative Disorders · doi:10.23937/2643-4539/1710019 · Cited by 5
Wang, F., Wang, J., Chen, T., Wang, S., Meng, X., Shen, Y., & Xu, X. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04826-4 · Cited by 4
Role of the microbiome in the development of Parkinson's disease (Review)
Gushi, S., & Derdas, S. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.374 · Cited by 4
Willows, S. D., Alam, S. B., Sandhu, J. K., & Kulka, M. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0341 · Cited by 4
Ko, Y., Kim, S., Pan, C., & Park, K. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3100893 · Cited by 4
Braun, A., Racz, J., Garg, S., & Bobrovskaya, L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106054 · Cited by 3
Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578755 · Cited by 2
Toxic trail from the gut to the brain
Berghe, P. V. (2022) · Gut · doi:10.1136/gutjnl-2021-326456 · Cited by 2
Central dopaminergic control of cell proliferation in the colonic epithelium
Yu, S., Peng, H., Zhang, Y.-K., Yin, Y., & Zhou, J. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.02.006 · Cited by 2
Катунина, Е. А., Semenova, A. M., & Katunin, D. A. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412401138 · Cited by 2
The gut microbiome in animal models of Parkinson’s disease
Morais, L. H., Fonseca, M. D. C., & Sampson, T. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13550-7.00010-0 · Cited by 2
Samur, D. N. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177932 · Cited by 2
Motavallian, A., Ghazizadeh, F., Khoshbin, S. P., Karimian, P., & Torshkooh, F. A. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_606_24 · Cited by 1
Impact of aging on the central and enteric nervous system in a Parkinson’s disease mouse model
Pradeloux, S., André, M. M., Fréchette, M., Drolet, M., Fontaine-lavallée, C., Côté, M., Coulombe, K., Rieux, M., Calon, F., & Soulet, D. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1576325 · Cited by 1
Song, X., Li, N., Li, X., Yuan, B., Zhang, X., Li, S., Yang, X., Qi, B., Yin, S., Li, C., et al. (2026) · Marine Drugs · doi:10.3390/md24010042 · Cited by 1
García, J. J. F., & Hinojosa, I. G. (2020) · Revista panorama/Panorama. Cuba y salud · Cited by 1
Grunho, M., Godinho, C., Patita, M., Mocanu, I., Vieira, A., de Matos, A., Carregosa, R., Marx, F., Tomé, M., Sousa-Catita, D., et al. (2021) · International Congress of CiiEM (IC CiiEM) · doi:10.3390/msf2021005028 · Cited by 1
Liu, H., Ren, M., Wang, H., Zhang, M., & Xiong, J. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.933 · Cited by 1
Yeske, B., Hou, J., Chu, D. Y., Adluru, N., Nair, V. A., Beniwal-Patel, P. M., Saha, S., & Prabhakaran, V. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1210939 · Cited by 1
New insights in non-motor symptoms in Parkinson’s disease
Falup‐Pecurariu, C., Fanciulli, A., Borgohain, R., Chaudhuri, К. R., & Metta, V. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4722-9 · Cited by 1
Colonoscopy and Subsequent Risk of Parkinson’s Disease
Holtz, A.-V., Fink, A., Tamgüney, G., & Doblhammer, G. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240017 · Cited by 1
Majeed, O. A., AlLami, M. Q., & AlGawwam, G. (2024) · Journal of Angiotherapy · doi:10.25163/angiotherapy.859642 · Cited by 1
Barroso, H., & Castro, C. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-2238-8
(2021) · Elsevier eBooks · doi:10.1016/b978-0-323-88445-7.16001-4
Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches
Катунина, Е. А., Shipilova, N. N., & Katunin, D. A. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212208121
THE NEGATIVE EFFECT OF PARKINSON'S DISEASE ON THE PATIENT'S PSYCHOLOGICAL AND SOCIAL WELL-BEING
Lauková, J., Šupínová, M., Frčová, Z., Janiczeková, E., Ivaničová, D., & Jankovičová, J. (2022) · Ošetřovatelské perspektivy · doi:10.25142/osp.2022.009
Colonic diverticular disease as a risk factor for neurodegenerative and associated diseases
Paley, E. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19122-0.00023-6
COLITIS ULCERATIVA Y MANIFESTACIONES NEUROPSIQUIÁTRICAS: REVISIÓN DE TEMA
Montalvo, C. M. M. (2024) · REVISTA ARGENTINA DE MEDICINA · doi:10.61222/ram.v12i2.959
谭, 林. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.41016
Comorbidity of inflammatory bowel diseases and Parkinson’s disease
Трухан, Д. И., Konshu, N. V., & Олеговна, М. П. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-170
MITScan : Score-Based Genome-Wide Association Analysis of the Microbiome and Host TranscriptomePreprint
Hao, Y., Kafri, T., & Zou, F. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.24.661342
Sui, Y., Teng, Y., Zhou, L., Jiang, L., Peng, S., Wei, S., & Chunchun, H. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1625050
Experiência Profissionalizante na vertente de Investigação, Farmácia Hospitalar e Comunitária
Pires, I. M. A. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Score-Based Genome-Wide Association Analysis of High-Dimensional Multi-Omics Data
Hao, Y. B. (2025) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/5m64-3b93
Gut bacterial Infection drives Parkinsonian pathology in LRRK2 G2019S Knock-in MicePreprint
Wang, Y., Weber, M. A., Stodden, N., Ziebarth, L., Lingappa, S., Borjabustamante, M., Balakrishnan, T., Jaily, M., Sakaguchi, T., Thangavel, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.728789
Advances in research on comorbidities in inflammatory bowel disease
Zhou, S., & yang, Y. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i5.385
Li, J., Ru, W., ZHAO, Y., & Liu, C. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s604053
MicroRNA: role in pathogenesis, problems of microRNA therapy, and future prospects
Kugaevskaya, E. V., Timoshenko, O. S., Gureeva, T. A., & Lisitsa, A. V. (2026) · Biomeditsinskaya Khimiya · doi:10.18097/pbmcr1705
Tao, W., Yu, Y., Huang, X., Huang, J., Wang, N., Shangguan, X., Yu, R., & Xiao, F. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1806356
Doença de Parkinson: uma ligação entre sistemas.
Costa, H. C. X. E. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Cui, G., Li, S., Ye, H., Yang, Y., Huang, Q., Chu, Y., Shi, Z., & Zhang, X. (2022) · doi:10.3389/fimmu.2022.956005.s001
Yeske, B., Hou, J., Chu, D. Y., Adluru, N., Nair, V. A., Beniwal-Patel, P., Saha, S., & Prabhakaran, V. (2024) · doi:10.3389/fnins.2024.1210939.s002
Zong, J., Yang, Y., Wang, H., Zhang, H., Yang, X., & Yang, X. (2024) · doi:10.3389/fimmu.2024.1325908.s002
Metadata
- Authors
- Brudek, T.
- Affiliations
- Frederiksberg Hospital (DK)
- Corresponding author
- Brudek, Tomasz
- ORCID
- Brudek, Tomasz
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2019-10-08
- Volume
- 9
- Issue
- s2
- Pages
- S331-S344
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC6839501
- OpenAlex
- W2980273606
- Cited by
- 139
- References
- 142
- Citations by year
- 2026: 6 · 2025: 23 · 2024: 21 · 2023: 17 · 2022: 32 · 2021: 31 · 2020: 8 · 2019: 1
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, inflammatory bowel disease, gut-brain axis, alpha-synuclein, Lewy bodies, dopaminergic neuron loss, intestinal inflammation, gut microbiota, glial activation, inflammatory cytokines, intestinal infection, IBD treatment, disease risk
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Parkinson Disease, Inflammatory Bowel Diseases, Enteric Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.